For research use only. Not for therapeutic Use.
Clorgyline Hydrochloride(CAT: I002307) is a selective and irreversible inhibitor of monoamine oxidase A (MAO-A), widely used in neuropharmacology and psychiatric research. By inhibiting MAO-A, it prevents the breakdown of monoamines such as serotonin, norepinephrine, and dopamine, making it a valuable tool for studying the regulation of mood, anxiety, and neurodegenerative diseases. Researchers utilize Clorgyline Hydrochloride to explore its effects on neurotransmitter metabolism, antidepressant mechanisms, and oxidative stress-related neuronal damage. Its specificity and effectiveness make it an essential compound for preclinical studies focused on mood disorders, Parkinson’s disease, and other neuropsychiatric conditions.
| CAS Number | 17780-75-5 |
| Synonyms | N-[3-(2,4-dichlorophenoxy)propyl]-N-methyl-2-propyn-1-amine, monohydrochloride |
| Molecular Formula | C₁₃H₁₅Cl₂NO • HCl |
| Purity | ≥95% |
| Target | Monoamine Oxidase |
| Solubility | DMSO: 20 mg/mL |
| Storage | Store at -20°C |
| IUPAC Name | 3-(2,4-dichlorophenoxy)-N-methyl-N-prop-2-ynylpropan-1-amine;hydrochloride |
| InChI | InChI=1S/C13H15Cl2NO.ClH/c1-3-7-16(2)8-4-9-17-13-6-5-11(14)10-12(13)15;/h1,5-6,10H,4,7-9H2,2H3;1H |
| InChIKey | BBAZDLONIUABKI-UHFFFAOYSA-N |
| SMILES | CN(CCCOC1=C(C=C(C=C1)Cl)Cl)CC#C.Cl |
